SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001511164-12-000128
Filing Date
2012-06-14
Accepted
2012-06-14 14:12:39
Documents
11
Period of Report
2012-04-30
Filing Date Changed
2012-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q neurokineform10qq1april3012.htm 10-Q 233708
8 EXHIBIT 31.1 neurokinesection302certceoq1.htm EX-31 7735
9 EXHIBIT 31.2 neurokinesection302certcfoq1.htm EX-31 7819
10 EXHIBIT 32.1 neurokinesection906certceoq1.htm EX-32 5673
11 EXHIBIT 32.2 neurokinesection906certcfoq1.htm EX-32 5659
  Complete submission text file 0001511164-12-000128.txt   1375913

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT neukf-20120430.xml EX-101.INS 170279
3 XBRL TAXONOMY EXTENSION SCHEMA neukf-20120430.xsd EX-101.SCH 12409
4 XBRL TAXONOMY EXTENSION CALCULATION SCHEMA neukf-20120430_cal.xml EX-101.CAL 5850
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neukf-20120430_def.xml EX-101.DEF 42231
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE neukf-20120430_lab.xml EX-101.LAB 76097
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neukf-20120430_pre.xml EX-101.PRE 55835
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-161157 | Film No.: 12907245
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1